We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

NCI-MATCH Trial will Link Targeted Cancer Drugs to Gene Abnormalities

News   Jun 09, 2015

 
NCI-MATCH Trial will Link Targeted Cancer Drugs to Gene Abnormalities
 
 
Advertisement
 

RELATED ARTICLES

Genes Increase Risk of Obesity but Also Protect Against Disease

News

Genes have been identified that are linked to both higher levels of body fat and protection from some negative health Impacts caused by obesity.

READ MORE

CD4 T Lymphocytes Shown To Kill Cancer Cells Directly

News

Scientists found that when the CD4 T lymphocytes were directly put in close contact with cancer cells, up to a third of them could also kill them.

READ MORE

Neanderthal Protein May Reduce the Severity of COVID-19

News

Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE